Emetrol Chewables Tablet, Chewable
NDC Package 65197-204-42
Package Information
Emetrol Chewables (sodium citrate dihydrate) tablets is adults: 2-4 tablets. This formulation utilizes a tablet, chewable delivery system. Marketed by Wellspring Pharmaceutical Corporation, this product is identified by NDC 65197-204.
Identification & Billing
- RxCUI: 2002800 - sodium citrate 230 MG Chewable Tablet
- RxCUI: 2596185 - Emetrol Chewables 230 MG Chewable Tablet
- RxCUI: 2596185 - sodium citrate 230 MG Chewable Tablet [Emetrol Chewables]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65197 - Wellspring Pharmaceutical Corporation
- 65197-204 - Emetrol Chewables
- 65197-204-42 - 1 BOTTLE in 1 BOX / 42 TABLET, CHEWABLE in 1 BOTTLE
- 65197-204 - Emetrol Chewables
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65197-204-42 identifies a specific commercial package of 1 bottle in 1 box / 42 tablet, chewable in 1 bottle of Emetrol Chewables, a human over the counter drug labeled by Wellspring Pharmaceutical Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet, chewable is formulated for oral use and contains trisodium citrate dihydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wellspring Pharmaceutical Corporation on March 15, 2022. The current certification is valid through December 31, 2026.
How is this Wellspring Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65197020442. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.